%0 Journal Article
%T 利用Foldit平台探索KCNQ1激活剂结构以对抗长QT综合征<br>Exploring the Structure of KCNQ1 Activators by the Foldit Platform to Combat Long QT Syndrome
%A 余亮
%A 陈弈诺
%A 唐林奥
%A 陈俊宇
%A 叶梓轩
%A 叶胜星
%A 焦佳丽
%J Bioprocess
%P 39-43
%@ 2164-5582
%D 2025
%I Hans Publishing
%R 10.12677/bp.2025.151006
%X 长QT综合征是一种与心脏复极化异常相关的遗传性疾病&#65292;其特征为心电图上QT间期延长&#65292;增加心脏骤停和猝死的风险。KCNQ1钾离子通道蛋白在维持正常心律中发挥着关键作用&#65292;其功能受损是长QT综合征的主要原因之一。本研究利用Foldit平台对KCNQ1激活剂的结构进行预测和优化&#65292;旨在为长QT综合征的治疗提供新的策略。通过模拟&#8211;分析&#8211;模拟循环的方法&#65292;调整分子的空间构型以优化其功能&#65292;并探讨了不同取代基对分子稳定性和活性的影响。本研究不仅为KCNQ1激活剂的设计提供了新的方向&#65292;也展示了高中生直接参与前沿科学研究的潜力。<br>Long QT syndrome (LQTS) is a genetic disorder associated with abnormal cardiac repolarization, characterized by a prolonged QT interval on electrocardiograms, which increases the risk of cardiac arrest and sudden death. The KCNQ1 potassium channel protein plays a critical role in maintaining normal cardiac rhythm, and its impaired function is a primary cause of LQTS. This study utilizes the Foldit platform to predict and optimize the structure of KCNQ1 activators, aiming to develop novel therapeutic strategies for LQTS. Through a simulation-analysis-simulation iterative approach, we adjusted molecular spatial configurations to enhance functionality and explored the effects of different substituents on molecular stability and activity. Our work not only provides new directions for the design of KCNQ1 activators but also demonstrates the potential for high school students to directly engage in cutting-edge scientific research.
%K 药物设计&#65292
%K Foldit&#65292
%K 长QT综合征<br>Drug Design
%K Foldit
%K Long QT Syndrome
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=109009